UNSPSC 51181631: Dextrothyroxine sodium

This classification denotes a thyroid agent with the molecular formula C15H10I4NO4.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0H00N2AHSP, chemically known as 3,3,5,5-tetraiodo-d-thyronine, sodium salt but more generally known as dextrothyroxine sodium, which bears US NIH Compound Identifier 8729. European Medicines Agency schedules Dextrothyroxine sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07055MIG.

Most nations, for tariff and trade purposes, schedule dextrothyroxine sodium under HS 29225000 and SITC 51467. As of Q4 2014, DEXTROTHYROXINE SODIUM remains US FDA's Preferred Term for this commodity. Dextrothyroxine sodium bears US NLM identifiers UMLS NCI C65373. SMILES: C1C(CC(C(C1I)OC2CC(C(C(C2)I)O)I)I)C[C@H](C(=O)[O-])N.O.[NA+].

UNSPSC 51181631 Dextrothyroxine sodium is a Commodity code for a synthetic thyroid hormone used in state and local health procurement. State and local governments purchase this pharmaceutical for use in public health clinics, correctional facilities, hospital systems operated by counties or municipalities, and health departments serving specific patient populations. The substance appears in procurement records as a line item within broader pharmaceutical supply contracts or standalone pharmaceutical acquisitions by public health entities.

The recent-opportunities block contains no solicitations. Without current procurement activity in the source data, no issuing-body mix, geographic concentration, or representative opportunities can be characterized at this time.